Tucatinib
About
Therapy type: Targeted therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Tucatinib (coding:ncit:C77896)
RxNorm: tucatinib (coding:rxcui:2361285, coding:omop:1145571)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Trastuzumab, Tucatinib | |
| FDA (2) | HER2-positive, Wild type KRAS, Wild type NRAS | Colorectal Adenocarcinoma | Trastuzumab, Tucatinib |